DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft model

Author:

Aalam Syed Mohammed Musheer1,Tang Xiaojia2,Song Jianning1,Ray Upasana1,Russell Stephen J3,Weroha S John45,Bakkum-Gamez Jamie6,Shridhar Viji1,Sherman Mark E7,Eaves Connie J89,Knapp David J H F110,Kalari Krishna R2,Kannan Nagarajan11112ORCID

Affiliation:

1. Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, MN, USA

2. Department of Health Sciences Research, Mayo Clinic , Rochester, MN, USA

3. Department of Molecular Medicine, Mayo Clinic , MN 55905, USA

4. Department of Oncology, Mayo Clinic , Rochester, MN, USA

5. Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic , Rochester, MN, USA

6. Division of Gynecologic Oncology Surgery, Department of Obstetrics and Gynecology, Mayo Clinic , Rochester, MN, USA

7. Department of Quantitative Health Sciences, Mayo Clinic , Jacksonville, FL, USA

8. Terry Fox Laboratory, British Columbia Cancer Research Institute , Vancouver, BC, Canada

9. Departments of Medical Genetics and School of Biomedical Engineering, University of British Columbia , Vancouver, BC, Canada

10. Institut de Recherche en Immunologie et Cancérologie, and Département de Pathologie et Biologie Cellulaire, Université de Montréal , Montreal, QC, Canada

11. Mayo Clinic Cancer Center, Mayo Clinic , Rochester, MN, USA

12. Center for Regenerative Medicine, Mayo Clinic , Rochester, MN, USA

Abstract

Abstract A problematic feature of many human cancers is a lack of understanding of mechanisms controlling organ-specific patterns of metastasis, despite recent progress in identifying many mutations and transcriptional programs shown to confer this potential. To address this gap, we developed a methodology that enables different aspects of the metastatic process to be comprehensively characterized at a clonal resolution. Our approach exploits the application of a computational pipeline to analyze and visualize clonal data obtained from transplant experiments in which a cellular DNA barcoding strategy is used to distinguish the separate clonal contributions of two or more competing cell populations. To illustrate the power of this methodology, we demonstrate its ability to discriminate the metastatic behavior in immunodeficient mice of a well-established human metastatic cancer cell line and its co-transplanted LRRC15 knockdown derivative. We also show how the use of machine learning to quantify clone-initiating cell (CIC) numbers and their subsequent metastatic progeny generated in different sites can reveal previously unknown relationships between different cellular genotypes and their initial sites of implantation with their subsequent respective dissemination patterns. These findings underscore the potential of such combined genomic and computational methodologies to identify new clonally-relevant drivers of site-specific patterns of metastasis.

Funder

Mayo Clinic's Department of Laboratory Medicine and Pathology

Mayo-NCI Breast Cancer

Ovarian Cancer

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3